1. Home
  2. RLJ vs ANIP Comparison

RLJ vs ANIP Comparison

Compare RLJ & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ

RLJ Lodging Trust of Beneficial Interest $0.01 par value

HOLD

Current Price

$11.42

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$75.10

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLJ
ANIP
Founded
2011
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2011
1999

Fundamental Metrics

Financial Performance
Metric
RLJ
ANIP
Price
$11.42
$75.10
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$7.83
$110.00
AVG Volume (30 Days)
1.8M
326.9K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
7.26%
N/A
EPS Growth
N/A
419.23
EPS
0.12
2.32
Revenue
$1,349,860,000.00
$206,547,000.00
Revenue This Year
$2.02
$21.01
Revenue Next Year
$2.54
$17.59
P/E Ratio
$95.67
$33.33
Revenue Growth
N/A
2.47
52 Week Low
$6.54
$70.15
52 Week High
$12.89
$99.50

Technical Indicators

Market Signals
Indicator
RLJ
ANIP
Relative Strength Index (RSI) 47.77 40.88
Support Level $10.86 $74.33
Resistance Level $12.11 $83.43
Average True Range (ATR) 0.39 2.55
MACD -0.04 -0.04
Stochastic Oscillator 32.81 17.30

Price Performance

Historical Comparison
RLJ
ANIP

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: